Dissemination of Colorectal Cancer Screening to Primary Care Physicians

This study has been completed.
Sponsor:
Collaborator:
American Cancer Society, Inc.
Information provided by:
Columbia University
ClinicalTrials.gov Identifier:
NCT00441311
First received: February 26, 2007
Last updated: January 28, 2011
Last verified: January 2011
  Purpose

The aim is to assess the efficacy of an intervention, academic detailing, a brief, frequently repeated educational program, on increasing recommendations for colorectal cancer screening among primary care providers by comparison to a service-as-usual control. The study is a stratified randomized clinical trial of primary care physicians, stratified by distinct urban communities in the New York metropolitan area. The primary outcome is colorectal cancer screening recommendations measured via medical audit at 12-month followup after randomization.


Condition Intervention Phase
Colorectal Cancer
Behavioral: Academic Detailing
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Screening
Official Title: Dissemination of Colorectal Cancer Screening to Primary Care Physicians

Resource links provided by NLM:


Further study details as provided by Columbia University:

Primary Outcome Measures:
  • Colorectal cancer screening recommendations [ Time Frame: Up to 12 months from the time of randomization ] [ Designated as safety issue: No ]

Enrollment: 264
Study Start Date: May 2003
Study Completion Date: September 2006
Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Academic Detailing
The academic detailing intervention will involve multiple components some of which are standardized across physicians (i.e. self-learning packets, newsletters). Detailing will also be customized to each physician, although the frequency of the detailing visits will be routinized across all participants to reduce cost and to maximize its potential for dissemination.
Behavioral: Academic Detailing
The academic detailing intervention will involve multiple components some of which are standardized across physicians (i.e. self-learning packets, newsletters). Detailing will also be customized to each physician, although the frequency of the detailing visits will be routinized across all participants to reduce cost and to maximize its potential for dissemination.
Other Name: Academic Detailing
No Intervention: Service-as-Usual
Control Arm

Detailed Description:

The purpose of the present study is to adapt and extend the use of academic detailing to the dissemination of colorectal cancer (CRC) screening findings and guidelines to primary care physicians practicing in selected geographic areas in New York City. Since improving implementation of cancer screening guidelines also involves compliance by patients in completing the recommended tests or examinations, we will also seek to assess knowledge, attitude and screening behaviors of patients visiting primary care practitioners in our sample. Our long-term goal is to reduce colorectal cancer mortality among ethnic and racial minorities, by influencing the screening behaviors of their primary care physicians.

The specific aims of the study are as follows:

  • Aim 1. To test the hypothesis that an intervention, multi-component academic detailing, will increase the rate of physician CRC screening at 3and 6month postrandomization, compared to the rate observed in a serviceasusual control.
  • Aim 2. To develop models predicting which physician offices are most and least likely to adopt the intervention, and to generate hypotheses about tailoring the dissemination of CRC screening guidelines to different physician subgroups.
  • Aim 3. To conduct cost-effectiveness analysis comparing the incremental societal costs and effects (in lives saved, life-years saved, and quality-of-life-years saved) of the CRC intervention implemented in physicians' offices.
  Eligibility

Ages Eligible for Study:   50 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Devote at least 50% of their practice to primary care
  • Work in the study communities
  • Are non-hospital based community practitioners
  • Have no immediate plans to retire or to leave their practice.

Exclusion Criteria:

  • Specialty physicians
  • Intend to retire or otherwise leave practice over course of the study
  • Other conditions that would preclude meaningful participation
  • Not working in study communities
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00441311

Locations
United States, New York
Columbia University Medical Center
New York, New York, United States, 10032
Sponsors and Collaborators
Columbia University
American Cancer Society, Inc.
Investigators
Principal Investigator: Sherri Sheinfeld Gorin, PhD Columbia University
  More Information

Publications:
Responsible Party: Sherri Gorin, PhD, Columbia University Medical Center
ClinicalTrials.gov Identifier: NCT00441311     History of Changes
Other Study ID Numbers: AAAA6315
Study First Received: February 26, 2007
Last Updated: January 28, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Columbia University:
colorectal cancer screening
primary care physicians
health disparities
stratified randomized clinical trial

Additional relevant MeSH terms:
Colorectal Neoplasms
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Rectal Diseases

ClinicalTrials.gov processed this record on October 23, 2014